Catalyst Wire Dossier Catalyst Wire Dossier

Softacort

hydrocortisone 0.335%
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Softacort, covering 2019-08-13 to 2019-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Efficacy of Topical Hydrocortisone 0.335% (Softacort®) in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation [Phase 4]

See pricing